Interleukin-6 and krebs von den lungen-6 in lymphangioleiomyomatosis patients

被引：0
|
作者：
Perea, Beatrice [1 ]
D'Alessandro, Miriana [1 ]
Bergantini, Laura [1 ]
Gangi, Sara [1 ]
Zilio, Benedetta [1 ]
Cameli, Paolo [1 ]
Bargagli, Elena [1 ]
机构：
[1] Univ Siena, Dept Med & Surg Sci & Neurosci, Resp Dis & Lung Transplantat Unit, I-53100 Siena, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA3949
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Krebs von den Lungen-6 as a Potential Predictive Biomarker in Fibrosing Interstitial Lung Diseases
    Lederer, Christoph
    Mayer, Katharina
    Somogyi, Vivien
    Kriegsmann, Katharina
    Kriegsmann, Mark
    Buschulte, Katharina
    Polke, Markus
    Findeisen, Peter
    Herth, Felix
    Kreuter, Michael
    RESPIRATION, 2023, 102 (08) : 591 - 600
  • [22] Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019
    Peng, Ding-Hui
    Luo, Yi
    Huang, Li-Jun
    Liao, Fan-Lu
    Liu, Yan-Yuan
    Tang, Peng
    Hu, Han-Ning
    Chen, Wei
    CLINICA CHIMICA ACTA, 2021, 517 : 48 - 53
  • [23] Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis
    Masahiko Shigemura
    Yasuyuki Nasuhara
    Satoshi Konno
    Chikara Shimizu
    Kazuhiko Matsuno
    Etsuro Yamaguchi
    Masaharu Nishimura
    Journal of Translational Medicine, 10
  • [24] Blood Krebs von den Lungen-6 predicts mortality in patients with acute exacerbation of interstitial lung disease
    Choi, Myeong Geun
    Yoon, Jung-Ki
    Choi, Sun Mi
    Song, Jin Woo
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [25] Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer
    Tanaka, Sonosuke
    Hattori, Noboru
    Ishikawa, Nobuhisa
    Shoda, Hiroyasu
    Takano, Atsushi
    Nishino, Ryohei
    Okada, Morihito
    Arihiro, Koji
    Inai, Kouki
    Hamada, Hironobu
    Yokoyama, Akihito
    Kohno, Nobuoki
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (02) : 377 - 387
  • [26] Serum Krebs von den Lungen-6 level predicts disease progression in interstitial lung disease
    Ko, Ui Won
    Cho, Eun Jung
    Oh, Heung-Bum
    Koo, Hyun Jung
    Do, Kyung-Hyun
    Song, Jin Woo
    PLOS ONE, 2020, 15 (12):
  • [27] Baseline serum Krebs von den Lungen-6 as a biomarker for the disease progression in idiopathic pulmonary fibrosis
    Chung, Chiwook
    Kim, Jiwon
    Cho, Hyo Sin
    Kim, Ho Cheol
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [28] Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease
    d'Alessandro, Miriana
    Conticini, Edoardo
    Bergantini, Laura
    Mazzei, Maria Antonietta
    Bellisai, Francesca
    Selvi, Enrico
    Cameli, Paolo
    Frediani, Bruno
    Bargagli, Elena
    TISSUE & CELL, 2024, 90
  • [29] Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung
    Takanashi, Satoshi
    Nishina, Naoshi
    Nakazawa, Maho
    Kaneko, Yuko
    Takeuchi, Tsutomu
    RHEUMATOLOGY, 2019, 58 (06) : 1034 - 1039
  • [30] Serum Krebs von den Lungen-6 (KL-6) level as a prognostic biomarker in patients with interstitial lung abnormalities (ILA)
    Park, Hye Kyeong
    Yoon, Young-Soon
    Song, Jae-Uk
    Kang, Hyung Koo
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
12345